Cardioprotective Effect of Cilostazol on Ischemia-Reperfusion Injury Model
- PMID: 34673517
- PMCID: PMC9713667
- DOI: 10.21470/1678-9741-2020-0651
Cardioprotective Effect of Cilostazol on Ischemia-Reperfusion Injury Model
Abstract
Introduction: To clarify the potential protective role of cilostazol on rat myocardial cells with ischemia-reperfusion injury (IRI) models.
Methods: The study was conducted with three groups of 10 Wistar rats (control group, rats without any coronary ischemia; sham group, rats with coronary ischemia but without cilostazol administration; and cilostazol group, rats with coronary ischemia and cilostazol administration). The level of myocardial injuries was measured by analyzing cardiac troponin T and creatine kinase MB levels in blood samples. In tissue samples, adenosine triphosphate (ATP), nitric oxide, superoxide dismutase (SOD), and malondialdehyde were used to determine the amount of tissue damage. Tissues were stained with hematoxylin-eosin method, and samples were examined under light microscope.
Results: The mean level of ATP was 104.4 in the cilostazol group and 149.1 in the sham group (P=0.044). SOD level was significantly higher in the cilostazol group than in the sham group (2075.3 vs. 1783.7, P=0.043). According to histopathological examination, all samples were classified as G0 in the control group. In the sham group, one sample was categorized as G1, six samples as G2, and three samples as G3. In the cilostazol group, nine samples and one sample were categorized as G1 and G2, respectively (P=0.011).
Conclusion: Cilostazol has beneficial effects on Wistar rats' myocardial cells in regard to decreasing inflammatory process, necrosis, and fibrosis. Our findings revealed that the use of cilostazol significantly decreased ATP and increased SOD levels in Wistar rats' myocardial cells after IRI.
Keywords: Adenosine Triphosphate; Cilostazol; Inflammation; Myocardial Ischemia; Superoxide Dismutase.
Conflict of interest statement
No conflict of interest.
Figures
Similar articles
-
Effects of Cilostazol on the Myocardium in an Obese Wistar Rat Model of Ischemia-Reperfusion Injury.Curr Vasc Pharmacol. 2023;21(4):268-273. doi: 10.2174/1570161121666230502141044. Curr Vasc Pharmacol. 2023. PMID: 37138441
-
Comparison of Cilostazol and Naftidrofuryl in an Experimental Acute Ischemia-Reperfusion Model.Vasc Endovascular Surg. 2021 Jan;55(1):11-17. doi: 10.1177/1538574420953944. Epub 2020 Sep 3. Vasc Endovascular Surg. 2021. PMID: 32878581
-
Cilostazol, a type III phosphodiesterase inhibitor, reduces ischemia/reperfusion-induced spinal cord injury.Heart Surg Forum. 2011 Jun;14(3):E171-7. doi: 10.1532/HSF98.20101126. Heart Surg Forum. 2011. PMID: 21676683
-
Effects of cilostazol on oxidative stress, systemic cytokine release, and spinal cord injury in a rat model of transient aortic occlusion.Ann Vasc Surg. 2014 Feb;28(2):479-88. doi: 10.1016/j.avsg.2013.08.005. Ann Vasc Surg. 2014. PMID: 24485778
-
Cilostazol attenuates spinal cord ischemia-reperfusion injury in rabbits.J Cardiothorac Vasc Anesth. 2015 Apr;29(2):351-9. doi: 10.1053/j.jvca.2014.06.028. Epub 2014 Nov 20. J Cardiothorac Vasc Anesth. 2015. PMID: 25440635
Cited by
-
Crosstalk among Reactive Oxygen Species, Autophagy and Metabolism in Myocardial Ischemia and Reperfusion Stages.Aging Dis. 2024 May 7;15(3):1075-1107. doi: 10.14336/AD.2023.0823-4. Aging Dis. 2024. PMID: 37728583 Free PMC article. Review.
-
An Experimental Rat Model Study: Is There Any Effect of Syringic Acid on Ischemia-Reperfusion Injury in Priapism?Cureus. 2023 Sep 18;15(9):e45475. doi: 10.7759/cureus.45475. eCollection 2023 Sep. Cureus. 2023. PMID: 37745750 Free PMC article.
References
-
- Santos MR, Celotto AC, Capellini VK, Evora PR, Piccinato CE, Joviliano EE. The protective effect of cilostazol on isolated rabbit femoral arteries under conditions of ischemia and reperfusion: the role of the nitric oxide pathway. Clinics (Sao Paulo) 2012;67(2):171–8. doi: 10.6061/clinics/2012(02)13. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous